Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212231 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yool Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and Physiology, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99202, USA. Hauptthemen laut MEDLINE: Fatty Acid-Binding Protein 7, Brain Neoplasms, Gene Expression Profiling, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, Hennings Cancer gift from the Elson S. Floyd College of Medicine.
Abstract (Originalsprache)
Fatty acid binding protein 7 (FABP7) is a multifunctional chaperone involved in lipid metabolism and signaling. It is primarily expressed in astrocytes and neural stem cells (NSCs), as well as their derived malignant glioma cells within the central nervous system. Despite growing evidence for FABP7’s tumor-intrinsic onco-metabolic functions, its mechanistic role in regulating the brain tumor immune microenvironment (TIME) and its impact on prognosis at the molecular level remain incompletely understood. Utilizing combined transcriptome profiling and pan-cancer analysis approaches, we report that FABP7 mediates the expression of multiple onco-immune drivers, collectively impacting tumor immunity and clinical outcomes across brain cancer subtypes. An analysis of a single-cell expression atlas revealed that FABP7 is predominantly expressed in the glial lineage and malignant cell populations in gliomas, with nuclear localization in their parental NSCs. Pathway and gene enrichment analysis of RNA sequencing data from wild-type (WT) and Fabp7-knockout (KO) mouse brains, alongside control (CTL) and FABP7-overexpressing (FABP7 OV) human astrocytes, revealed a more pronounced effect of FABP7 levels on multiple cancer-associated pathways. Notably, genes linked to brain cancer progression and tumor immunity (ENO1, MUC1, COL5A1, and IL11) were significantly downregulated (>2-fold) in KO brain tissue but were upregulated in FABP7 OV astrocytes. Furthermore, an analysis of data from The Cancer Genome Atlas (TCGA) showed robust correlations between the expression of these factors, as well as FABP7, and established glioma oncogenes (EGFR, BRAF, NF1, PDGFRA, IDH1), with stronger associations seen in low-grade glioma (LGG) than in glioblastoma (GBM). TIME profiling also revealed that the expression of FABP7 and the genes that it modulates was significantly associated with prognosis and survival, particularly in LGG patients, by influencing the infiltration of immunosuppressive cell populations within tumors. Overall, our findings suggest that FABP7 acts as an intracellular regulator of pro-tumor immunomodulatory genes, exerting a synergistic effect on the TIME and clinical outcomes in brain cancer subtypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine and Physiology, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99202, USA.
- Department of Integrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, WA 99164, USA.
- Sleep and Performance Research Center, Washington State University, Spokane, WA 99202, USA.
- Steve Gleason Institute for Neuroscience, Washington State University, Spokane, WA 99202, USA.
- Department of Organ Anatomy, Graduate School of Medicine, Tohoku University, Seiryo-cho 2-1, Aobaku, Sendai 980-8575, Japan.
ORCID-Profile: Yool Lee, Carlos C Flores, Micah Lefton, Jason R Gerstner
Förderung
- NIGMS NIH HHS
- NIH HHS
- Hennings Cancer gift from the Elson S. Floyd College of Medicine
- National Institutes of Health
- WSU Office of Research Advancement and Partnerships
Zitieren
APA
Lee, Y., Flores, C. C., Lefton, M., Bhoumik, S., Owada, Y., & Gerstner, J. R. (2024). Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212231
Vancouver
Lee Y, Flores CC, Lefton M, Bhoumik S, Owada Y, Gerstner JR. Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212231
BibTeX
@article{Lee2024,
author = {Lee, Yool and Flores, Carlos C and Lefton, Micah and Bhoumik, Sukanya and Owada, Yuji and Gerstner, Jason R},
title = {Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212231}
}
EUVIMED